CATALYSTYahoo • 1d ago
Edwards' Q3 Earnings on the Horizon: What's in the Cards?EW heads into Q3 with TAVR momentum, expanding mitral and tricuspid therapies and surgical heart growth. Can it beat earnings estimates?
Why EW Stock surged +2.90% Today — RQD Quant Desk Flash
$94.44 +2.90% NYSE • Public Delayed / 60s Snapshot
Edwards Lifesciences Corporation (EW) earns a Roarable Rating of B (Buy) with 72/100 RQD Confidence. High-quality cash engine (78% profit margin, 13% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
ROARABLE B • BUY
Cap $54.44B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERBUY • B
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw C · Rk A-
Each axis scored 0–20
12M PRICE TARGET CONE+6.3% Base Target
WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($5.5M)
44% PutsMax Pain: $93.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why EW Stock surged +2.90% Today — RQD Quant Desk Flash
Edwards Lifesciences Corporation (EW) surged +2.90% to $94.44 as options desks priced 56% call premium vs. 44% put protection around the $93 max-pain magnet. High-quality cash engine (78% profit margin, 13% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 91% of its 52-week range ($74.66 – $96.29) with RSI-14 at 59.9 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $5.5M in bullish call flow vs. $4.3M in put flow (Put/Call 0.79x, implied earnings swing ±7.2%).
- ▸Fundamental Anchor: Roarable B (Buy) backed by 78% gross margin and $1.3B annual free cash flow.
Live EW Headlines & Catalysts
MARKET WIREYahoo • 1d ago
Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key MetricsBeyond analysts' top-and-bottom-line estimates for Edwards Lifesciences (EW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended Sep
MARKET WIREYahoo • 2d ago
What Sent GE HealthCare Stock Higher?For questions about this article or underlying research, email help@trefis.com.
CATALYSTSeekingAlpha • 2d ago
Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio ThrivesEdwards Lifesciences earns a buy on FDA approvals, cardiology niche strength, and solid cash flow. Read here for a detailed analysis of EW stock.
CATALYSTYahoo • 3d ago
ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?PDEX heads into fiscal Q1 earnings with strong medical-device sales and margin momentum, but customer concentration, a shrinking backlog and acquisition risks loom.
CATALYSTYahoo • 3d ago
SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.
CATALYSTYahoo • 4d ago
WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.
CATALYSTYahoo • 4d ago
GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?GEHC heads into Q3 earnings with strong imaging demand and a record backlog, but PCS weakness, inflation and supply challenges could weigh on margins.
MARKET WIREBenzinga • 5d ago
$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much TodayEdwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 1.24% on an annualized basis producing an average annual return of 14.27%. Currently, Edwards Lifesciences has a market capitalization
CATALYSTYahoo • 8d ago
INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live EW Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
EW // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +10.19%▲ RESISTANCE BREAKOUT
2026-10-30O $94.55H $95.34L $91.87C $92.01VOL 6.04M
RES: $89.44SUP: $82.82SMA50: $88.14SMA200: $85.43
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
EW Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
36.7%/yr Implied 5Y Growth
vs. +11.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on EW today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for EW. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EW today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
EW Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is EW stock moving today?
Why EW Stock surged +2.90% Today — RQD Quant Desk Flash. High-quality cash engine (78% profit margin, 13% return on capital) with steady institutional support.